Hormone-related factors and gynecological conditions in relation to endometrial cancer risk
- PMID: 19554665
- DOI: 10.1097/cej.0b013e328329d830
Hormone-related factors and gynecological conditions in relation to endometrial cancer risk
Abstract
The objective of this study is to investigate the effect of menstrual and reproductive variables, breastfeeding, exogenous hormones, and gynecological conditions on endometrial cancer risk. We conducted a case-control study in Italy, including 454 women with endometrial cancer and 908 hospital controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariate logistic regression models. Endometrial cancer risk was inversely associated with age at menarche (OR = 0.7, 95% CI = 0.5-1.0, for > or =14 vs. <12 years), and directly associated with age at menopause (OR = 1.8, 95% CI = 1.1-2.7, for > or =55 vs. <50 years) and years of menstruation (OR = 2.4, 95% CI = 1.7-3.4, for highest vs. lowest tertile). Multiparity strongly reduced the risk among women under 60 years of age (OR = 0.3, 95% CI = 0.2-0.6, for > or =3 deliveries vs. <2). Oral contraceptive use conferred a 40% reduced risk (95% CI = 0.4-1.0), irrespective of time since cessation. Although based on small numbers, women with a history of treated infertility (OR = 2.7, 95% CI = 1.1-6.4) or endometriosis (OR = 4.0, 95% CI = 1.0-15.5) were at increased risks. No significant associations with endometrial cancer risk emerged for age at first/last birth, breastfeeding, menopausal status, hormone replacement therapy, and history of uterine fibromyomas or polycystic ovary. In conclusion, this study confirms the importance of multiparity, years of menstruation, and oral contraceptive use in endometrial cancer etiology, thus contributing to identify women at elevated risk of such neoplasm.
Similar articles
-
Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai.Int J Cancer. 2004 Feb 10;108(4):613-9. doi: 10.1002/ijc.11598. Int J Cancer. 2004. PMID: 14696129
-
Case-control study of endogenous steroid hormones and endometrial cancer.J Natl Cancer Inst. 1996 Aug 21;88(16):1127-35. doi: 10.1093/jnci/88.16.1127. J Natl Cancer Inst. 1996. PMID: 8757192
-
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.Int J Cancer. 2004 Jan 20;108(3):425-32. doi: 10.1002/ijc.11529. Int J Cancer. 2004. PMID: 14648710
-
Reproductive factors and breast cancer.Epidemiol Rev. 1993;15(1):36-47. doi: 10.1093/oxfordjournals.epirev.a036115. Epidemiol Rev. 1993. PMID: 8405211 Review.
-
The prevention of breast cancer through reduced ovarian steroid exposure.Acta Oncol. 1992;31(2):167-74. doi: 10.3109/02841869209088898. Acta Oncol. 1992. PMID: 1622631 Review.
Cited by
-
Endometriosis: a high-risk population for major chronic diseases?Hum Reprod Update. 2015 Jul-Aug;21(4):500-16. doi: 10.1093/humupd/dmv013. Epub 2015 Mar 11. Hum Reprod Update. 2015. PMID: 25765863 Free PMC article. Review.
-
Association of oral contraceptives and risk of endometrial cancer: A systematic review and meta-analysis.Acta Obstet Gynecol Scand. 2025 Apr;104(4):591-603. doi: 10.1111/aogs.15043. Epub 2025 Feb 21. Acta Obstet Gynecol Scand. 2025. PMID: 39981760 Free PMC article.
-
The Risk of Endometrial Cancer and Uterine Sarcoma Following Endometriosis or Pelvic Inflammatory Disease.Cancers (Basel). 2023 Jan 29;15(3):833. doi: 10.3390/cancers15030833. Cancers (Basel). 2023. PMID: 36765791 Free PMC article.
-
Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta‑analysis.Oncol Lett. 2023 Mar 8;25(4):168. doi: 10.3892/ol.2023.13754. eCollection 2023 Apr. Oncol Lett. 2023. PMID: 36960190 Free PMC article.
-
Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.JAMA. 2015 Jul 7;314(1):61-71. doi: 10.1001/jama.2015.6789. JAMA. 2015. PMID: 26151267 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources